Uzun Süreli Ranitidin Tedavisi alan Olguda Nondepolarizan Bloker Ajanlara Karşı Rezistans Gelişimi (Olgu Sunumu)

Öz

Biz bu yazıda, 65 yaşında, duodenal ülser nedeniyle uzun süredir ranitidine tedavisi gören ve üst gastrointestinal sistem kanaması nedeniyle opere olan erkek olguyu sunduk. Genel anestezi altında opere olan olguda nondepolarizan kas gevseticilerden vekuronium ve mivakuriuma karşı rezistans gelişti. Rezistans oluşturacak mekanizmalar arasında vekuronium ve mivakuriumun ranitidin ile etkileşmesi en büyük olasılıktır. ©2007, Fırat Üniversitesi, Tıp Fakültesi

Anahtar Kelimeler

• Nöromuskuler ilaçlara reziztans, vekuronium, mivakurium, ranitidine

Resistance to Nondepolarizing Blocking Agents in a Patient Prolonged Treatment with Ranitidine

Abstract

We report a case of a 65-year-old man with a history of duodenal ulcer that treated preoperatively with ranitidine and underwent surgical exploration for upper gastrointestinal hemorrhage under emergency conditions. Under general anaesthesia, he showed resistance to two nondepolarizing neuromuscular blocking drugs. No obvious cause for the resistance was demonstrated except for the possibility of an interaction between ranitidine with vecuronium and mivacurium. ©2007, Fırat Üniversitesi, Tıp Fakültesi

Keywords

• -

References

1. Martyn JAJ, Goudsouzian NG, Matteo RS, et al. Metocurine requirements and plasma concentrations in burned patients. Br J Anaesth 1983; 55: 265-268.
2. Shayevitz JR, Matteo RS. Decreased sensitivity to metocurine in patients with upper motoneuron disease. Anesth Analg 1985; 64: 767-772.
3. Brett RS, Schmidt JH, Gage JS, Schartel SA, Poppers PJ. Measurement of acetylcholine receptor concentration in skeletal muscle from apatient with multiple sclerosis and resistance to atracurium. Anesthesiology 1987; 66: 837-839.
4. Moorthy SS, Krishna G, Dierdorf SF. Resistance to vecuronium in patients with cerebral palsy. Anesth Analg 1991; 73: 275-277.
5. Gronert GA. Disuse atrophy with resistance to pancuronium. Anesthesiology 1981; 55: 547-549.
6. Metteo RS, Spector S, Horowitz PE. Relation of serum d- tubocurarine concentration to neuromuscular blockage in man. Anesthesiology 1974; 41: 440.
7. Ornstein E, Matteo R, Young W, Diaz Y. Resistance to metocurine-induced neuromuscular blockade in patients receiving phenytoin. Anesthesiology 1985; 63: 294-298.
8. Chen J, Kim YD, Dubosis M, Kammerer W, Macnamara TE. The increased requirement of pancuronium in neurosurgical patients receiving dilantin chronically. Anesthesiology 1983; 59: A288.

9. Parr SM, Galletly DC, Robinson BJ. Betamethasone-induced resistance to vecuronium: a potential problem in neurosurgery? Anaesth Intens Care 1991; 19: 103-105.
10. Azar I, Kumar D, Betcher AM. Resistance to pancuronium in an asthmatic patient treated with aminophyline and steroids. Can Anaesth Soc J 1982; 29: 280-282.
11. Katz B, Miledi R. The effect of calcium on acetyl choline release from motor nerve terminals. Proc R Soc (Biol) 1965; 161: 496.
12. Duvaldesten D, Agoston S. Pancuronium pharmacokinetics in a patient with liver cirrhosis. Br J Anaesth 1978; 50: 1131.
13. Mishra Y, Torda T, Ramzan I, Graham G. In-vıtro interaction between H2 antagonists and vecuronium. J Pharm Pharmacol 1994; 46 :205-208.
14. Platt PR, Thackray NM. Phenytoin-induced resistance to vecuronium. Anaesth Intensive care 1993; 21:185-191.
15. McCarthy G, Mirakhur RK, Elliott P, Wright J. Effect of H2 receptor antagonist pretreatment on vecuronium and atracurium induced neuromuscular block. Br J Anaesth 1991; 66: 713-715.
16. Roscoe S, Katende MD, Ivan D. Resistance to nondepolarizing muscle relaxants in a patient treated with ranitidine. The Mount Sınaı Journal of Medicine 1987; 54: 330-331.
17. Kabul Tarihi: 30.05.2006